Should you buy VTGN stock?
Last updated:
Based on market data through , StockInvest.us rates VistaGen Therapeutics Inc (VTGN) as a Sell Candidate with a technical score of -4.26 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 11.18%
- 3-month trend forecast Down 51.49%
- Easy Tracking In The Watchlist
Volatile ride for VistaGen Therapeutics Inc stock price on Monday moving between $0.260 and $0.300
(Market data through Aug 10, 2026)
The VistaGen Therapeutics Inc stock price fell by -8.28% on the last day (Monday, 10th Aug 2026) from $0.288 to $0.264. During the last trading day the stock fluctuated 15.38% from a day low at $0.260 to a day high of $0.300. The price has risen in 5 of the last 10 days and is up by 14.6% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -245 thousand shares and in total, 2 million shares were bought and sold for approximately $609.64 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
VTGN Signals & Forecast
There are mixed signals in the stock today. The VistaGen Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.274 and $0.320. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Tuesday, June 30, 2026, and so far it has risen 16.73%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.249 and $0.243. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $0.249. If this is broken, then the next support from accumulated volume will be at $0.243 and $0.226.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0400 between high and low, or 15.38%. For the last week the stock has had daily average volatility of 14.49%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (VTGN) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect VistaGen Therapeutics Inc to open at $0.275, and during the day (based on 14 day Average True Range), to move between $0.247 and $0.281, which gives a possible trading interval of +/-$0.0340 (+/-13.80%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 13.80% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.249 (5.65%) than the resistance at $0.284 (7.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is VistaGen Therapeutics Inc stock A Buy?
VistaGen Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-4.257
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.275 ( 4.09%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VTGN Performance
Trading levels for VTGN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.315 | 19.26% |
| R2 | 0.299 | 13.46% |
| R1 | 0.290 | 9.89% |
| Price | 0.264 | |
| S1 | 0.259 | -1.70% |
| S2 | 0.250 | -5.28% |
| S3 | 0.235 | -11.07% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.300 | 13.72% |
| R2 | 0.297 | 12.59% |
| R1 | 0.284 | 7.58% |
| Price | 0.264 | |
| S1 | 0.249 | -5.65% |
| S2 | 0.243 | -7.88% |
| S3 | 0.226 | -14.33% |
FAQ
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.
Buy VTGN